Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker (2009)
Sadr-Nabavi, A.,
Ramser, J.,
Volkmann, J.,
Naehrig, J.,
Wiesmann, F.,
Betz, B.,
...